目的调查结直肠癌患者UGT1A1基因UGT1A1*28和UGT1A1*6基因多态性的分布频率。方法收集我院80例结直肠癌患者外周血标本,提取基因组DNA.PCR扩增UGT1A1基因启动子和第1外显子基因片段,直接测序确定基因型。结果80例结直肠癌患者中.UGT1A1六28位点野生型TA6/6为55例(68.75%),杂合突变型TA6/7基因型22例(27.50%),纯和突变型TA7/7有3例(3.75%);UGT1A1*6位点突变型211GG基因型57例(71.25%),211GA基因型22例(27.50%),211AA基因型1例(1.25%)。等位基因出现频率分别为TA6为82.50%.TA7为17.50%.211G为85.00%.211A为15.00%。同时携带TA7和211A等位基因共6例(7.50%)。结论结直肠癌患者中UGT1A1*6和UGT1A1*28分布频率均较高,在测定UGT1A1基因多态性时应同时检测这两个突变位点。
Objective To investigate the frequency of UGT1A1 * 28 and UGT1A1 * 6 gene polymorphisms in colorectal cancer patients. Methods UGT1A1 * 28 and UGT1A1 * 6 genetic polymorphism analysis was performed in 80 patients with colorectal cancer. The UTG1A1 promoter region and exon 1 were amplified and direct sequencing. Results Of 80 patients, 55 cases(68.75%) were identified with TA6/6 genotype, 22 cases (27.50%) were heterozygous TA6/7, and 3 cases (3.75%) were the homozygous genotype (TA7/7) ; 57 case s ( 71.25 % ) were 211GG, 22 cases ( 27.50% ) were 211GA, and 1 case ( 1.25 % ) was 211AA. The allelic frequency of TA6 was 82.50%, TA7 was 17.50%, 211G was 85.00%, 211A was 15.00%. 6 cases (7.50%) were identified carrying both the heterozygous genotype UGT1A1 * 28 and UGT1A1 * 6. Conclusion In col- orectal cancer patients, the allelic frequency of UGT1A1 * 6 is equivalent with UGT1A1 * 28. Both of these two mutational sites should be tested when evaluating UGT1A1 genetic polymorphism.